BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16498573)

  • 1. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
    Bramer T; Dew N; Edsman K
    J Pharm Sci; 2006 Apr; 95(4):769-80. PubMed ID: 16498573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
    Dew N; Bramer T; Edsman K
    J Colloid Interface Sci; 2008 Jul; 323(2):386-94. PubMed ID: 18479696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
    Bramer T; Paulsson M; Edwards K; Edsman K
    Pharm Res; 2003 Oct; 20(10):1661-7. PubMed ID: 14620523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical applications for catanionic mixtures.
    Bramer T; Dew N; Edsman K
    J Pharm Pharmacol; 2007 Oct; 59(10):1319-34. PubMed ID: 17910806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
    Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
    Paulsson M; Edsman K
    Pharm Res; 2001 Nov; 18(11):1586-92. PubMed ID: 11758767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
    Dew N; Edwards K; Eriksson J; Edsman K; Björk E
    Colloids Surf B Biointerfaces; 2012 Jan; 89():53-60. PubMed ID: 21958537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Strategies in the Development of Catanionic Vesicles.
    Kuo AT; Chang CH
    J Oleo Sci; 2016 May; 65(5):377-84. PubMed ID: 27086996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alkyl chain asymmetry on catanionic mixtures of hydrogenated and fluorinated surfactants.
    Blanco E; Rodriguez-Abreu C; Schulz P; Ruso JM
    J Colloid Interface Sci; 2010 Jan; 341(2):261-6. PubMed ID: 19853859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of the viscosity peak in wormlike micellar solutions. 1. Mixed catanionic surfactants. A cryo-transmission electron microscopy study.
    Ziserman L; Abezgauz L; Ramon O; Raghavan SR; Danino D
    Langmuir; 2009 Sep; 25(18):10483-9. PubMed ID: 19572608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical spectroscopic and TEM studies of catanionic micelles of CTAB/SDS and their interaction with a NSAID.
    Chakraborty H; Sarkar M
    Langmuir; 2004 Apr; 20(9):3551-8. PubMed ID: 15875383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers.
    Paulsson M; Edsman K
    J Colloid Interface Sci; 2002 Apr; 248(1):194-200. PubMed ID: 16290522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catanionic surfactant vesicles for electrostatic molecular sequestration and separation.
    Lioi SB; Wang X; Islam MR; Danoff EJ; English DS
    Phys Chem Chem Phys; 2009 Nov; 11(41):9315-25. PubMed ID: 19830312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.
    Jiang Y; Li F; Luan Y; Cao W; Ji X; Zhao L; Zhang L; Li Z
    Int J Pharm; 2012 Oct; 436(1-2):806-14. PubMed ID: 22871561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysozyme in catanionic surfactant mixtures.
    Stenstam A; Khan A; Wennerström H
    Langmuir; 2004 Aug; 20(18):7760-5. PubMed ID: 15323529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous vesicle formation in catanionic mixtures of amino acid-based surfactants: chain length symmetry effects.
    Marques EF; Brito RO; Silva SG; Rodríguez-Borges JE; do Vale ML; Gomes P; Araújo MJ; Söderman O
    Langmuir; 2008 Oct; 24(19):11009-17. PubMed ID: 18720960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface deposition and phase behavior of oppositely charged polyion/surfactant ion complexes. 1. Cationic guar versus cationic hydroxyethylcellulose in mixtures with anionic surfactants.
    Svensson AV; Huang L; Johnson ES; Nylander T; Piculell L
    ACS Appl Mater Interfaces; 2009 Nov; 1(11):2431-42. PubMed ID: 20356112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation.
    Dew N; Edsman K; Björk E
    J Pharm Pharmacol; 2011 Oct; 63(10):1265-73. PubMed ID: 21899541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of monodisperse charged vesicles in mixtures of cationic gemini surfactants and anionic SDS.
    Prévost S; Wattebled L; Laschewsky A; Gradzielski M
    Langmuir; 2011 Jan; 27(2):582-91. PubMed ID: 21142021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.